1) Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
David J. Augeri, Jeffrey A. Robl, David A. Betebenner, David R. Magnin, Ashish Khanna, James G. Robertson, Aiying Wang, Ligaya M. Simpkins, Prakash Taunk, Qi Huang, Song-Ping Han, Benoni Abboa-Offei, Michael Cap, Li Xin, Li Tao, Effie Tozzo, Gustav E. Welzel, Donald M. Egan, Jovita Marcinkeviciene, Shu Y. Chang, Scott A. Biller, Mark S. Kirby, Rex A. Parker, and Lawrence G. Hamann
J. Med. Chem. 2005, 48(15). - pp 5025–5037
Код: Выделить всё
http://dx.doi.org/10.1021/jm050261p
Trevor W. Hayton, Peter Legzdins, and W. Brett Sharp
Chem Rev. - 2002 Volume 102, Issue 4 - pp 935–992
Код: Выделить всё
http://dx.doi.org/10.1021/cr000074t
Hans Ulrich Blaser
Chem Rev. 1992 Volume 92, Issue 5 - pp 935–952
Код: Выделить всё
http://dx.doi.org/10.1021/cr00013a009
Ryoji Noyori
Angew Chem Int Ed 2002,Volume 41 Issue 12, p 2008-2022
Код: Выделить всё
http://dx.doi.org/10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4
Masato Kitamura, Seiji Suga, Koji Kawai, Ryoji Noyori
J Am Chem Soc 1986 Volume 108, Issue 19, pp 6071–6072
Код: Выделить всё
http://dx.doi.org/10.1021/ja00279a083